Humana IncAnalyst report highlights Humana's weaker earnings outlook (expected 47.4% drop) and higher valuation multiple, indicating financial underperformance.
UnitedHealth Group appears better positioned than Humana among healthcare leaders, according to a Zacks Investment Research analysis. UnitedHealth benefits from a diversified platform spanning insurance, health services, and technology, while Humana remains more focused on Medicare. UnitedHealth trades at 20.57 times forward earnings with a 2.3% dividend yield, compared to Humana's 30.47 times multiple and 1% yield. Consensus estimates project UnitedHealth's 2026 earnings will rise 12.1%, whereas Humana's are expected to drop 47.4%. Both stocks carry a Zacks Rank #3, or Hold.
Humana IncAnalyst report highlights Humana's weaker earnings outlook (expected 47.4% drop) and higher valuation multiple, indicating financial underperformance.
UnitedHealth Group IncorporatedAnalyst report cites UnitedHealth's diversified model, stronger earnings growth (12.1% expected), and lower valuation multiple as advantages.